Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-09-26

Clinical Trial Update: Hyper Baric Oxygen Therapy (HBOT) for Spontaneous Osteonecrosis of the Knee [Phase 1]

View source ↗

Summary

An update on a Phase 1 trial evaluating hyperbaric oxygen therapy for spontaneous osteonecrosis of the knee, with the current status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Spontaneous Osteonecrosis of the Knee | Phase 1 | Status: UNKNOWN